Quinn Opportunity Partners’s Agilon Health AGL Stock Holding History

Quinn Opportunity Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Buy	+5,820	New	+$381K	0.03%	253

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quinn Opportunity Partners's AGL Position: Q2 2026 in Review

Quinn Opportunity Partners opened a new position in Agilon Health (AGL) in Q2 2026: 5,820 shares worth $624K. The stake represents 0.03% of the portfolio and ranks #253 among its holdings.

179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Quinn Opportunity Partners held 5,820 shares of Agilon Health worth $624K as of Q2 2026.
Agilon Health was a new Quinn Opportunity Partners position in Q2 2026.
Agilon Health made up 0.03% of Quinn Opportunity Partners's portfolio in Q2 2026, its #253 holding.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.